CClinicalTrials.gg
CompletedNCT07339241Updated Jan 14, 2026

Abdominal Circumference as a Predictor of Operative Time in Retroperitoneal Adrenalectomy for Pheochromocytoma

An observational study in Pheochromocytoma Malignant, sponsored by Asan Medical Center. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by Asan Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
159
Ages
18 Years and older
Sex
All
01

Study summary

This retrospective observational study examines whether abdominal circumference is associated with operative time in patients undergoing retroperitoneal adrenalectomy for pheochromocytoma. Data were collected from medical records of patients treated at a single tertiary referral center. The primary outcome is operative time, measured in minutes. The purpose of this study is to evaluate whether abdominal circumference can serve as a practical predictor of operative difficulty in retroperitoneal adrenalectomy.

02

Conditions studied

  • Pheochromocytoma Malignant

Browse trials for

Keywords

  • Pheochromocytoma
  • retroperitoneal adrenalectomy
  • operative time
  • abdominal circumference
03

In context

Pheochromocytoma

149 studies on the registry are indexed under Pheochromocytoma; 56 are open to participants now.

This study's enrollment of 159 is below the median of 186 across 54 observational studies indexed under Pheochromocytoma.

Browse Pheochromocytoma studies →

Lead sponsor

Asan Medical Center is the lead sponsor of 562 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult patients diagnosed with pheochromocytoma who underwent retroperitoneal adrenalectomy at a single tertiary referral center. Data were collected retrospectively from electronic medical records.

Inclusion criteria

  • Adult patients diagnosed with pheochromocytoma
  • Patients who underwent retroperitoneal adrenalectomy
  • Availability of complete operative records

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years
  • Patients who underwent transperitoneal adrenalectomy
  • Incomplete clinical or operative data
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
159 participants (actual)
Patient registry
No

Groups and cohorts

  • Pheochromocytoma Patients

    Patients diagnosed with pheochromocytoma who underwent retroperitoneal adrenalectomy at a single tertiary referral center. All procedures were performed as part of routine clinical care, and no experimental intervention was assigned for the purpose of this observational study.

    Procedure: Retroperitoneal Adrenalectomy

Interventions

  • ProcedureRetroperitoneal Adrenalectomy

    Retroperitoneal adrenalectomy performed as part of routine clinical care for patients with pheochromocytoma. No experimental intervention was assigned, and the surgical procedure was not altered for the purpose of this observational retrospective study.

06

What researchers measure

Primary outcomes

  1. Operative Time

    Operative time measured in minutes from skin incision to skin closure, obtained from operative records.

    Time frame: During surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07339241
Lead sponsor
Asan Medical Center
Responsible party
Byung-Chang Kim (MD, PhD, Asan Medical Center) — Principal investigator
First posted
Jan 14, 2026
Start date
Jan 2017
Primary completion
Dec 2021
Completion
Dec 2021
Last update
Jan 14, 2026

Study contacts

BYUNG-CHANG KIM, MD, PhD
principal investigator · Asan Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion